Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Sensenig Bethany, Director. Officer active across 3 companies, notably Supernus Pharmaceuticals, INC.. Aggregated, 6 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €205k. History available since 21 April 2023. The latest transaction was disclosed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Bethany Sensenig is a Board Member at Supernus Pharmaceuticals, Inc. She brings expertise in corporate governance and strategy. Her role involves overseeing operations and contributing to strategic decision-making within the company. Through her experience, she plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.